Lv3
270 积分 2024-11-14 加入
Long-term patient survival in ANCA-associated vasculitis
1个月前
已完结
Proteinuria and hematuria after remission induction are associated with outcome in ANCA-associated vasculitis
1个月前
已完结
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
1个月前
已完结
Recent pathogenetic insights and therapeutic advances in ANCA-associated vasculitis
2个月前
已完结
Integrating lymphovascular invasion and ypTNM staging system for esophageal squamous cell carcinoma undergoing neoadjuvant chemoradiotherapy and surgery: a multi-institutional analysis
4个月前
已完结
Pathogenesis and therapeutic interventions for ANCA-associated vasculitis
7个月前
已完结
Estrategias terapéuticas en las vasculitis asociadas a anticuerpos anticitoplasma de neutrófilo
7个月前
已关闭
C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN
7个月前
已完结
Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial
10个月前
已完结
Rituximab vs cyclophosphamide for cancer risk in ANCA-associated vasculitis
10个月前
已完结
皖公网安备34019202002308
